Evidence map›Paper›PMID 38550843›Full record

ReviewIndian dermatology online journal

Nail Society of India Recommendations for Treatment of Onychomycosis in Special Population Groups.

Khushbu Mahajan, Chander Grover, Vineet Relhan, Sushil Tahiliani, Archana Singal, Manjunath M Shenoy, Deepak Jakhar, Shikha Bansal

Abstract readReview
In one paragraph

Review in Indian dermatology online journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Onychomycosis in special populations.Future microbiology · 2025
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Khushbu MahajanMahajan Skin Centre and Kubba Skin Clinic, Delhi, India.
Chander GroverDepartment of Dermatology and STD, University College of Medical Sciences and GTB Hospital, Delhi, India.
Vineet RelhanDepartment of Dermatology and STD, Maulana Azad Medical College and LN Hospital, Delhi, India.
Sushil TahilianiHinduja Hospital and MRC, Dr Tahiliani's Skin Clinic, Mumbai, Maharashtra, India.
Archana SingalDepartment of Dermatology and STD, University College of Medical Sciences and GTB Hospital, Delhi, India.
Manjunath M ShenoyDepartment of Dermatology, Venereology and Leprosy, Yenepoya Medical College, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.
Deepak JakharDermosphere Skin Clinic, Delhi, India.
Shikha BansalDepartment of Dermatology and STD, Vardhman Mahavir Medical College and Safdarjung Hospital, Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Onychomycosis (OM) is a difficult-to-treat condition, especially considering the limited armamentarium of antifungal drugs, need for prolonged treatment, and poor compliance. This problem is further confounded while treating OM in special populations such as children, elderly, immunosuppressed patients, pregnant or lactating women, and patients with chronic liver or kidney disease. In the absence of standardized treatment guidelines, the antifungal therapy is either withheld or compromised, as it is largely governed by personal preferences or based on anecdotal reports. Hence, an expert group of the Nail Society of India worked towards drafting guidelines based on established literature and inputs from experts, with practical recommendations for the treatment of onychomycosis in special population groups. An extensive analysis of available English language literature on onychomycosis in special populations, published during a 10-year period (2014-2023 until date) was done. The available studies and reports were evaluated, cross-references read, and evidence compiled, graded, and discussed by the expert group to derive consensus recommendations for practice. The evidence and recommendations based on it are presented in a narrative format to guide treatment choices when dealing with population groups with special considerations.

Indexed as

Chronic kidney diseasechronic liver diseasegeriatricimmunosuppressionpediatricpregnancy

Identifiers

PMID38550843
PMCPMC10969234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.